Glucocorticoid effects on skeletal muscle: Benefit and risk in patients with autoimmune inflammatory rheumatoid diseases

Expert Review of Clinical Immunology

Volumn 8, Issue 8, 2012, Pages 695-697

  Hanaoka, Beatriz Y ^a   Peterson, Charlotte A ^b   Crofford, Leslie J ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

glucocorticoid; muscle; myopathy; steroid

Indexed keywords

GLUCOCORTICOID; PREDNISOLONE;

ADRENAL SUPPRESSION; AUTOINFLAMMATORY DISEASE; CACHEXIA; CATARACT; EDITORIAL; HOMEOSTASIS; HUMAN; HYPERTENSION; LIPODYSTROPHY; LONG TERM CARE; METABOLIC SYNDROME X; MUSCLE WEAKNESS; MYOPATHY; OSTEOPOROSIS; RHEUMATIC DISEASE; SIDE EFFECT; SKELETAL MUSCLE; WEIGHT GAIN;

ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; GENETIC PREDISPOSITION TO DISEASE; GLUCOCORTICOIDS; HOMEOSTASIS; HUMANS; IMMUNOSUPPRESSION; INDIVIDUALIZED MEDICINE; MUSCLE, SKELETAL; POLYMORPHISM, GENETIC; RECEPTORS, GLUCOCORTICOID; RISK; TREATMENT OUTCOME; WOUND HEALING;

EID: 84869783394     PISSN: 1744666X     EISSN: 17448409     Source Type: Journal    
DOI: 10.1586/eci.12.76     Document Type: Editorial

References (21)

1. van Staa TP, Leufkens HG, Abenhaim L, Begaud B, Zhang B, Cooper C. Use of oral corticosteroids in the United Kingdom. QJM 93(2), 105-111 (2000). (Pubitemid 30098773)
2. Hanaoka BY, Peterson CA, Horbinski C, Crofford LJ. Implications of glucocorticoid therapy in idiopathic inflammatory myopathies. Nat. Rev. Rheumatol. 8(8), 448-457 (2012).
3. Curtis JR, Westfall AO, Allison J et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum. 55(3), 420-426 (2006). (Pubitemid 43887028)
4. Fardet L, Cabane J, Kettaneh A, Lebbé C, Flahault A. Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome. Rheumatology 46(7), 1102-1106 (2007). (Pubitemid 47053780)
5. Gunnar BJ, Andersson M et al. The Burden of Musculoskeletal Diseases. American Academy of Orthopaedic Surgeons, IL, USA (2008).
6. van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C. Oral corticosteroids and fracture risk: Relationship to daily and cumulative doses. Rheumatology 39(12), 1383-1389 (2000). (Pubitemid 32045866)
7. Gran JT, Nordvåg BY. Referrals from general practice to an outpatient rheumatology clinic: Disease spectrum and analysis of referral letters. Clin. Rheumatol. 19(6), 450-454 (2000). (Pubitemid 32039664)
8. Hasselgren PO, Fischer JE. Counterregulatory hormones and mechanisms in amino acid metabolism with special reference to the catabolic response in skeletal muscle. Curr. Opin. Clin. Nutr. Metab. Care 2(1), 9-14 (1999). (Pubitemid 129628620)
9. Schakman O, Gilson H, Kalista S, Thissen JP. Mechanisms of muscle atrophy induced by glucocorticoids. Horm. Res. 72(Suppl. 1), 36-41 (2009).
10. Schakman O, Dehoux M, Bouchuari S et al. Role of IGF-I and TNF-α/NF-κB pathway in the induction of muscle atrogenes by acute inflammation. Am. J. Physiol. Endocrinol. Metab. 303(6), E729-E739 (2012).
11. Walsmith J, Roubenoff R. Cachexia in rheumatoid arthritis. Int. J. Cardiol. 85(1), 89-99 (2002).
12. Rall LC, Roubenoff R. Rheumatoid cachexia: Metabolic abnormalities, mechanisms and interventions. Rheumatology 43(10), 1219-1223 (2004). (Pubitemid 39359292)
13. Sultan SM, Ioannou Y, Moss K, Isenberg DA. Outcome in patients with idiopathic inflammatory myositis: Morbidity and mortality. Rheumatology 41(1), 22-26 (2002). (Pubitemid 34537916)
14. Lundberg IE. Idiopathic inflammatory myopathies: Why do the muscles become weak? Curr. Opin. Rheumatol. 13(6), 457-460 (2001). (Pubitemid 33070960)
15. Pereira RM, Freire de Carvalho J. Glucocorticoid-induced myopathy. Joint Bone. Spine 78(1), 41-44 (2011).
16. Dekhuijzen PN, Gayan-Ramirez G, Bisschop A, De Bock V, Dom R, Decramer M. Corticosteroid treatment and nutritional deprivation cause a different pattern of atrophy in rat diaphragm. J. Appl. Physiol. 78(2), 629-637 (1995).
17. Lacomis D, Zochodne DW, Bird SJ. Critical illness myopathy. Muscle Nerve 23(12), 1785-1788 (2000).
18. Douglass JA, Tuxen DV, Horne M et al. Myopathy in severe asthma. Am. Rev. Respir. Dis. 146(2), 517-519 (1992).
19. Dhand UK. Clinical approach to the weak patient in the intensive care unit. Respir. Care 51(9), 1024-1040; discussion 1040 (2006). (Pubitemid 44870534)
20. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: A major cause of muscle weakness and paralysis. Lancet Neurol. 10(10), 931-941 (2011).
21. Lacomis D, Giuliani MJ, Van Cott A, Kramer DJ. Acute myopathy of intensive care: Clinical, electromyographic, and pathological aspects. Ann. Neurol. 40(4), 645-654 (1996 (Pubitemid 26357890)